Every peptide, mapped to the body.

160 compounds, from approved medicines to early research molecules. Each one filed by the system research looks at, with its regulatory status and the strength of the evidence behind it.

Explore the map What UU carries

Compounds: 160
Research summaries: 39
At UU: 56

Approved medicine71
Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.
In clinical trials19
In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.
Research compound53
Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.
Cosmetic ingredient17
Used as a topical cosmetic ingredient. Cosmetic use is not a medicinal approval, and most evidence comes from manufacturer and small panel studies.

Reviewed October 2026

5-Amino-1MQAbaloparatideAcetyl tetrapeptide-5AfamelanotideAHK-CuAmycretinAngiotensin IIAOD-9604ApraglutideARA-290ArgirelineAtosibanBacitracinBivalirudinBPC-157BrilacidinBronchogenCagrilintideCagriSemaCalcitonin (salmon)CarnosineCartalaxCerebrolysinCetrorelixChonlutenCJC-1295 with DACCJC-1295 without DACColistinCortagenCorticotropinCosyntropinCyclosporineDalbavancinDaptomycinDasiglucagonDegarelixDersimelagonDesmopressinDifelikefalinDihexaDSIPDulaglutideEcallantideEfpeglenatideEnfuvirtideEnlicitideEpithalonEptifibatideEtelcalcetideExenatideFollistatin 344FOXO4-DRIGanirelixGHK-CuGHRP-2GHRP-6Glatiramer acetateGlepaglutideGlucagonGlutathioneGonadorelinGoserelinHexapeptide-9HexarelinHGH fragment 176-191HistrelinHuman chorionic gonadotropinHumaninIcatibantIGF-1 DESIGF-1 LR3Insulin analoguesIpamorelinKisspeptin-10KPVLanreotideLeuphasylLeuprolideLinaclotideLiraglutideLivagenLixisenatideLL-37LTX-315MacimorelinMatrixylMazdutideMecaserminMechano growth factorMelanotan IIMK-677MotixafortideMOTS-cNAD+NafarelinNangibotideNesiritideNNZ-2591Nonapeptide-1NormoftalOctreotideOligopeptide-1OvagenOxytocinP21Palmitoyl hexapeptide-12Palmitoyl tetrapeptide-7Palmitoyl tripeptide-1Palmitoyl tripeptide-38PalopegteriparatidePancragenPasireotidePegcetacoplanPegvisomantPemvidutidePetrelintidePinealonPlecanatidePramlintideProstamaxPT-141RetatrutideRusfertideSecretinSelankSemaglutideSemaxSermorelinSetmelanotideSincalideSLU-PP-332SNAP-8SomapacitanSomatropinSS-31SurvodutideSYN-AKETB-500TeduglutideTeriparatideTerlipressinTesamorelinTestagenThymalinThymogenThymosin alpha-1Thymosin beta-4ThymulinTirzepatideTripeptide-10 citrullineTriptorelinTrofinetideVancomycinVasopressinVesiluteVilonVIPVosoritideZiconotideZilucoplan

In the UU catalog

Researched, batch-tested, ready to ship.

Compounds UU carries that have a full research summary in the library.

Skin
Afamelanotide
Melanocortin agonist
Human trialsShop
Gut
Cagrilintide
Long-acting amylin analogue
Human trialsShop
Sexual
Oxytocin
Neurohypophyseal hormone
Human trialsShop
Sexual
PT-141
Melanocortin agonist
Human trialsShop
Gut
Semaglutide
GLP-1 receptor agonist
Human trialsShop
Heart
SS-31
Mitochondria-targeted tetrapeptide
Human trialsShop
Gut
Tesamorelin
GHRH analogue
Human trialsShop
Immune
Thymosin alpha-1
Thymic peptide
Human trialsShop
Gut
Tirzepatide
GIP and GLP-1 receptor agonist
Human trialsShop
Immune
VIP
Neuropeptide
Human trialsShop
Immune
ARA-290
Erythropoietin-derived peptide
Early human dataShop
Hormones
CJC-1295 with DAC
Long-acting GHRH analogue
Early human dataShop
Hormones
GHRP-2
Ghrelin receptor agonist
Early human dataShop
Skin
Glutathione
Antioxidant tripeptide
Early human dataShop
Hormones
Hexarelin
Ghrelin receptor agonist
Early human dataShop
Hormones
Ipamorelin
Ghrelin receptor agonist
Early human dataShop
Sexual
Kisspeptin-10
Kisspeptin receptor agonist
Early human dataShop
Immune
LL-37
Antimicrobial peptide
Early human dataShop
Gut
Retatrutide
GIP, GLP-1 and glucagon receptor agonist
Early human dataShop
Brain
Selank
Tuftsin analogue
Early human dataShop
Hormones
Sermorelin
GHRH analogue
Early human dataShop
Immune
Thymalin
Thymic peptide preparation
Early human dataShop
Gut
AOD-9604
Growth hormone fragment
Mixed evidenceShop
Hormones
CJC-1295 without DAC
GHRH analogue
Mixed evidenceShop
Brain
DSIP
Neuropeptide
Mixed evidenceShop
Skin
GHK-Cu
Copper tripeptide
Mixed evidenceShop
Hormones
GHRP-6
Ghrelin receptor agonist
Mixed evidenceShop
Cells
NAD+
Coenzyme
Mixed evidenceShop
Brain
Semax
ACTH(4-10) analogue
Mixed evidenceShop
Muscle
TB-500
Thymosin beta-4 related peptide
Mixed evidenceShop
Gut
5-Amino-1MQ
NNMT inhibitor
PreclinicalShop
Muscle
BPC-157
Gastric pentadecapeptide
PreclinicalShop
Brain
Dihexa
Angiotensin IV analogue
PreclinicalShop
Cells
Epithalon
Pineal tetrapeptide
PreclinicalShop
Hormones
IGF-1 LR3
IGF-1 analogue
PreclinicalShop
Gut
KPV
Alpha-MSH fragment
PreclinicalShop
Gut
MOTS-c
Mitochondrial-derived peptide
PreclinicalShop
Brain
Pinealon
Short bioregulator peptide
PreclinicalShop
Gut
SLU-PP-332
ERR agonist
PreclinicalShop

Sort

43 compounds · Gut & weight

Gut & weight43

Incretins, amylin analogues and gut peptides studied for appetite, glucose and body weight.

Shop LEAN

In trialsAt UU
Cagrilintide
Long-acting amylin analogue
A weekly amylin analogue in clinical trials, alone and combined with semaglutide, for weight reduction.
Human trialsShop
ApprovedAt UU
Semaglutide
Ozempic · Wegovy
GLP-1 receptor agonist
A long-acting GLP-1 analogue approved for type 2 diabetes and chronic weight management, in weekly injected and daily oral forms.
Human trialsShop
ApprovedAt UU
Tesamorelin
Egrifta
GHRH analogue
A growth hormone-releasing hormone analogue approved to reduce excess abdominal fat in HIV-associated lipodystrophy.
Human trialsShop
ApprovedAt UU
Tirzepatide
Mounjaro · Zepbound
GIP and GLP-1 receptor agonist
A dual incretin agonist approved for type 2 diabetes and chronic weight management.
Human trialsShop
ResearchAt UU
VIP
Vasoactive intestinal peptide · Aviptadil
Neuropeptide
A 28-residue neuropeptide found in gut, lung and brain. Studied as aviptadil in lung injury and inflammatory conditions.
Human trialsShop
In trialsAt UU
Retatrutide
LY3437943
GIP, GLP-1 and glucagon receptor agonist
A triple-receptor agonist in Phase 3 trials. Studied for weight reduction, type 2 diabetes and liver fat.
Early human dataShop
ResearchAt UU
AOD-9604
Tyr-hGH 177-191
Growth hormone fragment
A modified C-terminal fragment of human growth hormone. Studied for fat metabolism, with human obesity trials that did not reach their goals.
Mixed evidenceShop
ResearchAt UU
NAD+
Nicotinamide adenine dinucleotide
Coenzyme
A coenzyme in every cell, not a peptide. Its levels fall with age, which is why it appears in metabolic and ageing research.
Mixed evidenceShop
ResearchAt UU
5-Amino-1MQ
NNMT inhibitor
A small molecule, not a peptide, that blocks the enzyme NNMT. Studied in rodents for fat mass and muscle ageing.
PreclinicalShop
ResearchAt UU
BPC-157
Body protection compound-157 · PL 14736
Gastric pentadecapeptide
A 15-residue peptide based on a protein from human gastric juice. Studied mostly in rodents for tendon, muscle and gut repair.
PreclinicalShop
ResearchAt UU
KPV
Lys-Pro-Val
Alpha-MSH fragment
A tripeptide from the tail of alpha-MSH. Studied preclinically for intestinal inflammation and barrier function.
PreclinicalShop
ResearchAt UU
MOTS-c
Mitochondrial-derived peptide
A 16-residue peptide encoded in mitochondrial DNA. Studied for insulin sensitivity and exercise capacity in animal models.
PreclinicalShop
ResearchAt UU
SLU-PP-332
ERR agonist
A small molecule that activates estrogen-related receptors. Studied in mice as an exercise mimetic.
PreclinicalShop
ResearchAt UU
Livagen
Short bioregulator peptide
A tetrapeptide associated with liver tissue in Russian bioregulator research. Studied in cell models of chromatin ageing.
Summary pendingShop
ResearchAt UU
Ovagen
Short bioregulator peptide
A bioregulator peptide associated with liver and gut tissue in Russian research. Published evidence is limited.
Summary pendingShop
ResearchAt UU
Pancragen
Short bioregulator peptide
A bioregulator peptide associated with pancreatic tissue in Russian research. Published evidence is limited.
Summary pendingShop
In trials
Amycretin
GLP-1 and amylin receptor agonist
A single molecule acting at both GLP-1 and amylin receptors. In clinical trials in oral and injected forms.
Summary pending
In trials
Apraglutide
Long-acting GLP-2 analogue
A weekly GLP-2 analogue in clinical trials for short bowel syndrome and intestinal graft-versus-host disease.
Summary pending
In trials
CagriSema
Amylin and GLP-1 combination
A fixed combination of cagrilintide and semaglutide in Phase 3 trials for obesity and type 2 diabetes.
Summary pending
Approved
Dasiglucagon
Zegalogue
Glucagon analogue
A stable, ready-to-use glucagon analogue approved by the FDA for severe hypoglycaemia.
Summary pending
Approved
Dulaglutide
Trulicity
GLP-1 receptor agonist
A weekly GLP-1 analogue fused to an antibody fragment. Approved for type 2 diabetes.
Summary pending
In trials
Efpeglenatide
GLP-1 receptor agonist
A long-acting GLP-1 agonist studied in cardiovascular outcome trials in type 2 diabetes.
Summary pending
Approved
Exenatide
Byetta · Bydureon
GLP-1 receptor agonist
The first GLP-1 agonist, based on a peptide from Gila monster saliva. Approved for type 2 diabetes.
Summary pending
In trials
Glepaglutide
Long-acting GLP-2 analogue
A long-acting GLP-2 analogue studied in Phase 3 trials for short bowel syndrome.
Summary pending
Approved
Glucagon
Pancreatic hormone
The pancreatic hormone that raises blood glucose. Approved for severe hypoglycaemia and as a diagnostic aid.
Summary pending
Research
HGH fragment 176-191
Growth hormone fragment
The unmodified C-terminal region of growth hormone that AOD-9604 is based on. Studied in animal models of fat metabolism.
Summary pending
Approved
Insulin analogues
Glargine · Lispro
Insulin
Engineered forms of the 51-residue pancreatic hormone, with faster or longer action. Approved for diabetes.
Summary pending
Approved
Lanreotide
Somatuline
Somatostatin analogue
A long-acting somatostatin analogue approved for acromegaly and neuroendocrine tumours.
Summary pending
Approved
Linaclotide
Linzess · Constella
Guanylate cyclase-C agonist
An oral peptide that acts in the gut lining. Approved for irritable bowel syndrome with constipation.
Summary pending
Approved
Liraglutide
Victoza · Saxenda
GLP-1 receptor agonist
A daily GLP-1 analogue approved for type 2 diabetes and weight management.
Summary pending
Approved
Lixisenatide
Lyxumia
GLP-1 receptor agonist
A short-acting GLP-1 agonist approved for type 2 diabetes, also sold combined with insulin glargine.
Summary pending
In trials
Mazdutide
IBI362 · LY3305677
GLP-1 and glucagon receptor agonist
A dual agonist approved in China and in trials elsewhere. Studied for weight reduction and type 2 diabetes.
Summary pending
Approved
Octreotide
Sandostatin
Somatostatin analogue
A somatostatin analogue approved for acromegaly and symptoms of neuroendocrine tumours.
Summary pending
In trials
Pemvidutide
ALT-801
GLP-1 and glucagon receptor agonist
A dual agonist studied for obesity and liver fat in Phase 2 trials.
Summary pending
In trials
Petrelintide
Long-acting amylin analogue
A weekly amylin analogue in Phase 2 trials for weight management.
Summary pending
Approved
Plecanatide
Trulance
Guanylate cyclase-C agonist
An oral analogue of uroguanylin approved by the FDA for chronic constipation.
Summary pending
Approved
Pramlintide
Symlin
Amylin analogue
The first amylin analogue, approved by the FDA as an add-on to mealtime insulin in diabetes.
Summary pending
Approved
Secretin
ChiRhoStim
Gut hormone
The first hormone ever described. Approved as a diagnostic agent for pancreatic function.
Summary pending
Approved
Setmelanotide
Imcivree
MC4R agonist
A melanocortin-4 receptor agonist approved for obesity caused by specific rare genetic variants.
Summary pending
Approved
Sincalide
Kinevac
Cholecystokinin fragment
The C-terminal octapeptide of cholecystokinin. Approved as a diagnostic agent for gallbladder imaging.
Summary pending
In trials
Survodutide
BI 456906
GLP-1 and glucagon receptor agonist
A dual agonist in Phase 3 trials for obesity and fatty liver disease.
Summary pending
Approved
Teduglutide
Gattex · Revestive
GLP-2 analogue
A GLP-2 analogue approved for short bowel syndrome.
Summary pending
Approved
Terlipressin
Terlivaz
Vasopressin analogue
A vasopressin prodrug approved for hepatorenal syndrome, and in Europe for bleeding oesophageal varices.
Summary pending

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.